FEV1 (% predicted): mean change from baseline · adults and children with cystic fibrosis and a positive microbiological isolate of P aeruginosa from a respiratory tract specimen
1 finding from 1 review
FVC · adults and children with cystic fibrosis and a positive microbiological isolate of P aeruginosa from a respiratory tract specimen
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Pulmonary exacerbations: rate of PDEs per participant year · adults and children with cystic fibrosis and a positive microbiological isolate of P aeruginosa from a respiratory tract specimen
Summary of findings: continuous cycles alternating aztreonam lysine… showed no clear difference in pulmonary exacerbations: rate of PDEs per participant year compared with continuous cycles alternating placebo with tobramycin (low certainty).
1 finding from 1 review
Quality of life: respiratory domain · adults and children with cystic fibrosis and a positive microbiological isolate of P aeruginosa from a respiratory tract specimen
1 finding from 1 review
Survival · adults and children with cystic fibrosis and a positive microbiological isolate of P aeruginosa from a respiratory tract specimen
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events: any adverse event in the comparative phase · adults and children with cystic fibrosis and a positive microbiological isolate of P aeruginosa from a respiratory tract specimen
Summary of findings: continuous cycles alternating aztreonam lysine… showed no clear difference in adverse events: any adverse event in the comparative phase compared with continuous cycles alternating placebo with tobramycin (low certainty).
1 finding from 1 review
Adverse events · adults and children with cystic fibrosis and a positive microbiological isolate of P aeruginosa from a respiratory tract specimen
1 finding from 1 review
FEV1 (% predicted): mean change from baseline · adults and children with cystic fibrosis and a positive microbiological isolate of P aeruginosa from a respiratory tract specimen
1 finding from 1 review
FVC (% predicted) Change from baseline · adults and children with cystic fibrosis and a positive microbiological isolate of P aeruginosa from a respiratory tract specimen
1 finding from 1 review
Clinical failure · adults and children with enteric fever
Cefixime may leads to higher clinical failure compared with fluoroquinolones (low certainty).
1 finding from 1 review
Clinical failure · adults and children with enteric fever
It is very uncertain whether ceftriaxone changes clinical failure compared with fluoroquinolones (very low certainty).
1 finding from 1 review
Microbiological failure · adults and children with enteric fever
It is very uncertain whether ceftriaxone changes microbiological failure compared with fluoroquinolones (very low certainty).
1 finding from 1 review
Relapse · adults and children with enteric fever
It is very uncertain whether ceftriaxone changes relapse compared with fluoroquinolones (very low certainty).
1 finding from 1 review
Time to defervescence · adults and children with enteric fever
It is very uncertain whether ceftriaxone changes time to defervescence compared with fluoroquinolones (very low certainty).
1 finding from 1 review
Length of hospital stay · adults and children with enteric fever
1 finding from 1 review
Microbiological failure · adults and children with enteric fever
Cefixime showed no clear difference in microbiological failure compared with fluoroquinolones (low certainty).
1 finding from 1 review
Convalescent faecal carriage · adults and children with enteric fever
It is very uncertain whether ceftriaxone changes convalescent faecal carriage compared with fluoroquinolones (very low certainty).
1 finding from 1 review
Serious adverse events · adults and children with enteric fever
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Relapse · adults and children with enteric fever
Cefixime may leads to higher relapse compared with fluoroquinolones (low certainty).
1 finding from 1 review
Time to defervescence · adults and children with enteric fever
Cefixime may leads to higher time to defervescence compared with fluoroquinolones (low certainty).
1 finding from 1 review